Interference of dibutylphthalate on human prostate cell viability.

Area of Science:

• Environmental Health
• Endocrinology
• Prostate Cancer Research

Background:

• Dibutylphthalate (DBP) is a widespread environmental pollutant and plasticizer found in numerous consumer products.
• DBP is classified as an endocrine disrupting chemical (EDC) with demonstrated effects on reproductive systems.
• Exposure to DBP can occur through ingestion, inhalation, skin contact, or intravenous routes.

Purpose of the Study:

• To investigate the effects of DBP on human prostate adenocarcinoma cells (LNCaP).
• To compare the influence of DBP with 17β-estradiol (E2) on prostate cells.
• To elucidate the role of xenoestrogens in prostate physiology and cell cycle regulation.

Main Methods:

• Assessed cell viability following exposure to DBP and 17β-estradiol.
• Evaluated gene and protein expression related to cell cycle regulation.
• Observed the expression and cellular localization of estrogen receptors (ERs) and androgen receptors (AR).

Main Results:

• DBP demonstrated interaction with the estrogen receptor pathway, distinct from 17β-estradiol.
• DBP exposure altered normal prostate gland physiology.
• DBP was implicated in the deregulation of the prostate cell cycle.

Conclusions:

• DBP interacts with estrogenic pathways in a manner different from 17β-estradiol.
• DBP disrupts normal prostate gland function and contributes to cell cycle dysregulation.
• Xenoestrogen exposure, exemplified by DBP, poses a risk to prostate health.